XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
Total
Class A Common Stock
Class V Common Stock
Members' Equity
Common Stock
Class A Common Stock
Common Stock
Class V Common Stock
Retained Earnings / (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Total Stockholders' Equity (Deficit) Attributable to biote Corp.
Non Controlling Interest
Beginning balance, units at Dec. 31, 2020       982,800            
Beginning balance at Dec. 31, 2020 $ (17,075,000)           $ (17,052,000) $ (23,000) $ (17,075,000)  
Distributions (2,342,000)           (2,342,000)   (2,342,000)  
Net income (loss) 8,841,000           8,841,000   8,841,000  
Other comprehensive income (loss) (9,000)             (9,000) (9,000)  
Ending balance, units at Mar. 31, 2021       982,800            
Ending balance at Mar. 31, 2021 (10,585,000)           (10,553,000) (32,000) (10,585,000)  
Beginning balance, units at Dec. 31, 2020       982,800            
Beginning balance at Dec. 31, 2020 (17,075,000)           (17,052,000) (23,000) (17,075,000)  
Net income (loss) 27,139,000                  
Ending balance, units at Sep. 30, 2021       982,800            
Ending balance at Sep. 30, 2021 (1,353,000)           (1,316,000) (37,000) (1,353,000)  
Beginning balance, units at Mar. 31, 2021       982,800            
Beginning balance at Mar. 31, 2021 (10,585,000)           (10,553,000) (32,000) (10,585,000)  
Distributions (5,625,000)           (5,625,000)   (5,625,000)  
Net income (loss) 9,761,000           9,761,000   9,761,000  
Other comprehensive income (loss) 10,000             10,000 10,000  
Ending balance, units at Jun. 30, 2021       982,800            
Ending balance at Jun. 30, 2021 (6,439,000)           (6,417,000) (22,000) (6,439,000)  
Distributions (3,436,000)           (3,436,000)   (3,436,000)  
Net income (loss) 8,537,000           8,537,000   8,537,000  
Other comprehensive income (loss) (15,000)             (15,000) (15,000)  
Ending balance, units at Sep. 30, 2021       982,800            
Ending balance at Sep. 30, 2021 (1,353,000)           (1,316,000) (37,000) (1,353,000)  
Beginning balance, units at Dec. 31, 2021       982,800            
Beginning balance at Dec. 31, 2021 4,125,000           4,165,000 (40,000) 4,125,000  
Distributions (2,735,000)           (2,735,000)   (2,735,000)  
Net income (loss) 9,350,000           9,350,000   9,350,000  
Other comprehensive income (loss) 6,000             6,000 6,000  
Ending balance, units at Mar. 31, 2022       982,800            
Ending balance at Mar. 31, 2022 10,746,000           10,780,000 (34,000) 10,746,000  
Beginning balance, units at Dec. 31, 2021       982,800            
Beginning balance at Dec. 31, 2021 4,125,000           4,165,000 (40,000) 4,125,000  
Net income (loss) (11,485,000)                  
Share-based compensation 0                  
Issuance of shares under SEPA, shares     48,565,824              
Ending balance at Sep. 30, 2022 (70,847,000)       $ 1,000 $ 5,000 (48,119,000) (6,000) (48,119,000) $ (22,728,000)
Ending balance, shares at Sep. 30, 2022         8,339,158 48,565,824        
Beginning balance, units at Mar. 31, 2022       982,800            
Beginning balance at Mar. 31, 2022 10,746,000           10,780,000 (34,000) 10,746,000  
Net loss through May 26, 2022 (207,000)           (207,000)   (207,000)  
Other comprehensive income (loss) (5,000)             (5,000) (5,000)  
Beginning balance, units at Mar. 31, 2022       982,800            
Beginning balance at Mar. 31, 2022 10,746,000           10,780,000 (34,000) 10,746,000  
Distributions (6,840,000)           (6,840,000)   (6,840,000)  
Business Combination: Capitalized transaction costs (12,282,000)           (12,282,000)   (12,282,000)  
Share-based compensation 79,270,000           79,270,000   79,270,000  
Settlement of phantom equity rights (7,250,000)           (7,250,000)   (7,250,000)  
Ending balance at Jun. 30, 2022 (71,312,000)       $ 1,000 $ 5,000 (49,144,000) (5,000) (49,143,000) (22,169,000)
Ending balance, shares at Jun. 30, 2022         7,574,271 48,565,824        
Business Combination: Reverse recapitalization on May 26, 2022, units       (982,800)            
Business Combination: Reverse recapitalization on May 26, 2022 (113,622,000) $ 1,000 $ 5,000       (113,628,000)   (113,622,000)  
Business Combination: Reverse recapitalization on May 26, 2022, shares   7,574,271 48,565,824              
Business Combination: Noncontrolling interest on May 26, 2022             3,619,000 34,000 3,653,000 (3,653,000)
Net income (loss) (21,122,000)           (2,606,000)   (2,606,000) (18,516,000)
Ending balance at Jun. 30, 2022 (71,312,000)       $ 1,000 $ 5,000 (49,144,000) (5,000) (49,143,000) (22,169,000)
Ending balance, shares at Jun. 30, 2022         7,574,271 48,565,824        
Distributions (1,035,000)                 (1,035,000)
Net income (loss) 494,000           15,000   15,000 479,000
Other comprehensive income (loss) (4,000)             (1,000) (1,000) (3,000)
Share-based compensation 746,000           746,000   746,000  
Vesting of RSUs         699,887          
Issuance of shares under SEPA 264,000           264,000   264,000  
Issuance of shares under SEPA, shares         65,000          
Ending balance at Sep. 30, 2022 $ (70,847,000)       $ 1,000 $ 5,000 $ (48,119,000) $ (6,000) $ (48,119,000) $ (22,728,000)
Ending balance, shares at Sep. 30, 2022         8,339,158 48,565,824